These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 439900)
21. Spontaneous murine mammary adenocarcinoma: model system for evaluation of combined methods of therapy. Stolfi RL; Martin DS; Fugmann RA Cancer Chemother Rep; 1971 Jun; 55(3):239-51. PubMed ID: 4329953 [No Abstract] [Full Text] [Related]
22. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intratumoral doxorubicin injection in a rat breast tumor model. Goldberg SN; Saldinger PF; Gazelle GS; Huertas JC; Stuart KE; Jacobs T; Kruskal JB Radiology; 2001 Aug; 220(2):420-7. PubMed ID: 11477246 [TBL] [Abstract][Full Text] [Related]
23. Prophylactic and therapeutic actions of supplemental beta-carotene in mice inoculated with C3HBA adenocarcinoma cells: lack of therapeutic action of supplemental ascorbic acid. Rettura G; Stratford F; Levenson SM; Seifter E J Natl Cancer Inst; 1982 Jul; 69(1):73-7. PubMed ID: 6954324 [TBL] [Abstract][Full Text] [Related]
24. Tumoricidal response induced by cytosine arabinoside after plasma perfusion over protein A. Terman DS; Yamamoto T; Tillquist RL; Henry JF; Cook GL; Silvers A; Shearer WT Science; 1980 Sep; 209(4462):1257-9. PubMed ID: 7403885 [TBL] [Abstract][Full Text] [Related]
25. Topical and intratumoral photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma. Casas A; Fukuda H; Meiss R; Batlle AM Cancer Lett; 1999 Jul; 141(1-2):29-38. PubMed ID: 10454240 [TBL] [Abstract][Full Text] [Related]
26. Synthesis of a coupled tumor antigen with specificity against transplanted tumors in C3H/HeJ mice. Phillip MJ; Maximuke PP Oncology; 1980; 37(1):1-5. PubMed ID: 6153125 [TBL] [Abstract][Full Text] [Related]
27. Histologic monitoring of murine mammary tumor lysis induced by an autologous serum factor. Roy M; Friedman F; Piliero SJ; Jacobs M; Bonomo RA; Grob HS Proc Soc Exp Biol Med; 1982 Apr; 169(4):506-18. PubMed ID: 7071063 [No Abstract] [Full Text] [Related]
28. Mechanisms underlying reduced growth rate in C3HBA mammary adenocarcinomas recurring after single doses of x-rays or fast neutrons. Nelson JS; Carpenter RE; Durboraw D Cancer Res; 1976 Feb; 36(2 Pt 1):524-31. PubMed ID: 1260751 [TBL] [Abstract][Full Text] [Related]
29. Biology and therapeutic response of a mouse mammary adenocarcinoma (16/C) and its potential as a model for surgical adjuvant chemotherapy. Corbett TH; Griswold DP; Roberts BJ; Peckham JC; Schabel FM Cancer Treat Rep; 1978 Oct; 62(10):1471-88. PubMed ID: 709550 [TBL] [Abstract][Full Text] [Related]
30. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide--VIII. Fisher B; Gebhardt MC; Saffer EA Int J Radiat Oncol Biol Phys; 1978; 4(11-12):975-82. PubMed ID: 721660 [No Abstract] [Full Text] [Related]
31. The effect of cooling on the photodynamic action of hematoporphyrin derivative during interstitial phototherapy of solid tumors. 1983 Second-Place Resident Research Award: basic category. Jones GC; Kinsey JH; Neel HB; Cortese DA Otolaryngol Head Neck Surg; 1984 Oct; 92(5):532-6. PubMed ID: 6239128 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic efficacy and apoptosis and necrosis kinetics of doxorubicin compared with cisplatin, combined with whole-body hyperthermia in a rat mammary adenocarcinoma. Toyota N; Strebel FR; Stephens LC; Matsuda H; Oshiro T; Jenkins GN; Bull JM Int J Cancer; 1998 May; 76(4):499-505. PubMed ID: 9590125 [TBL] [Abstract][Full Text] [Related]
34. Experimental and clinical trials with BCG immunotherapy. Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024 [No Abstract] [Full Text] [Related]
35. Combined treatment with radioestradiol-lucanthone in mouse C3HBA mammary adenocarcinoma and with estradiol-lucanthone in an estrogen bioassay. Padawer J; Rettura G; Thysen B; Gatz M; Seifter E Int J Radiat Oncol Biol Phys; 1981 Mar; 7(3):349-57. PubMed ID: 7275712 [No Abstract] [Full Text] [Related]
36. Therapeutic electromagnetic field effects on angiogenesis and tumor growth. Williams CD; Markov MS; Hardman WE; Cameron IL Anticancer Res; 2001; 21(6A):3887-91. PubMed ID: 11911264 [TBL] [Abstract][Full Text] [Related]
37. Eradication of spontaneous and experimental adenocarcinoma metastases with chronic indomethacin and intermittent IL-2 therapy. Lala PK; Parhar RS Int J Cancer; 1993 Jun; 54(4):677-84. PubMed ID: 8514459 [TBL] [Abstract][Full Text] [Related]
38. Metastasis of murine mammary tumour lines from the mammary gland and ectopic sites. Unemori EN; Ways N; Pitelka DR Br J Cancer; 1984 May; 49(5):603-14. PubMed ID: 6722008 [TBL] [Abstract][Full Text] [Related]
39. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. V. Comparison of the effects of tilorone hydrochloride, levamisole, methanol-soluble fraction of Mycobacterium butyricum, BCG, and a nonviable aqueous ether extract of Brucella abortus preparation in treatment of mice with tumors. Fisher B; Linta J; Hanlon J; Saffer E J Natl Cancer Inst; 1978 Feb; 60(2):391-9. PubMed ID: 413929 [No Abstract] [Full Text] [Related]
40. Rejection of mammary adenocarcinoma cell tumors and the prevention of progressive growth of incipient metastases following intratumor permeation with killed Bordetella pertussis. Likhite VV Cancer Res; 1974 Oct; 34(10):2790-4. PubMed ID: 4370327 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]